-
EGFR+ Lung Cancer: Going Beyond Osimertinib
Learn about what's next once osimertinib stops working in EGFR+ lung cancer. EGFR Resisters co-founders Jill Feldman and Ivy Elkins, and 2021 EGFR Resisters/LUNGevity Foundation... -
A Survivor’s Experience with Biomarker Testing and TKI Treatments
Back in 2013, when Dan Cadigan was first diagnosed with stage III lung cancer, his treatment options were limited to surgery followed by chemotherapy. However, at his one-year... -
Being a Caregiver for a Parent
Being a caregiver for a parent means helping in different ways and playing different roles. For Aimee Yairi, it started when her dad told her that he was having a lingering cough... -
Beloved Reporter Goes Public with His Lung Cancer Diagnosis
A familiar voice to many in the greater Washington, DC area, Neal Augenstein, a beloved reporter at WTOP radio, joined fellow lung cancer survivor Melinda Ojermark to discuss his... -
What the End of the COVID Public Health Emergency Means for You
It’s been more than 3 years since the US Department of Health and Human Services (HHS) first declared a nationwide Public Health Emergency (PHE) due to COVID-19. Since then... -
Joanne G. Shares her Story
My lung cancer journey began back in February 2021, by happenstance. I didn’t have any of the classic symptoms, other than I didn’t feel well and I was unusually tired. I... -
10 Reasons to Attend LUNGevity’s HOPE Summit
HOPE Summit is a weekend conference unlike any other! The Summit brings hundreds of people affected by lung cancer together to build their community, give and get support, and... -
Tackling the Biggest Challenges in Cancer
Cancer Grand Challenges is a partnership between Cancer Research UK (CRUK) and the National Cancer Institute (NCI), which funds global teams of leading researchers across various... -
Let Your Voice Be Heard!
We are collecting stories from patients, caregivers, friends, and family members! Tell us how lung cancer has affected your life. Email your story to us at support@lungevity.org... -
Finding Clinical Trials for Lung Cancer: Tools and Resources
Clinical trials are an important option for patients because the newest treatment approaches, not available otherwise, are being tested in them. Clinical trial research leads to... -
RET, MET, and EGFR: An unusual tale of three oncogenes in lung cancer
LUNGevity's Upal Basu Roy, PhD, MPH, Executive Director, Research, discusses innovative research into RET+ NSCLC with patient advocates and the scientist conducting the studies... -
Fuel for the Future: Good Nutrition for the Lung Cancer Community
Learn valuable information about good nutrition that can help you live well through lung cancer treatment and beyond. Gain insight and tips from Oncology Dietitian Lori Bumbaco, MS...
EGFR